Drug
Indacaterol maleate clinical trials
A product of Indacaterol; its studies count on that page too.
- studies test it
- 14
- open now
- 0
- in phase 3
- 3
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 9
- Phase 3
- 3
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 2
Novartis (6) · Novartis Pharmaceuticals (5) · University of Milan (2) · Mundipharma Research Limited (1)
Often tested with
Tested in the same studies.
Glycopyrrolate (3) · Mometasone Furoate (3) · Indacaterol acetate (2)
Studies
Open first, then newest update. How each study uses indacaterol maleate is read from its arms, and is right about nine times in ten.
Testing it · 14
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedPhase 2Novartis PharmaceuticalsNCT03257995Written as Indacaterol maleate
- Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaCompletedPhase 1NovartisNCT00624702Written as Indacaterol maleate
- Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedPhase 4Novartis PharmaceuticalsNCT02202616Written as Glycopyrronium /Indacaterol maleate
- Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedPhase 4Novartis PharmaceuticalsNCT01985334Written as Indacaterol maleate and glycopyrronium bromide
- A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated EosinophilsTerminatedPhase 2/3Mundipharma Research LimitedNCT02693769Written as Indacaterol maleate / glycopyrronium bromide capsules
- Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent AsthmaCompletedPhase 2/3NovartisNCT00403637Written as indacaterol maleate
- A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 DeviceCompletedPhase 2Novartis PharmaceuticalsNCT01484197Written as 75 µg indacaterol maleate (LB)
- Closing Volume Interpretation and Bronchodilators EffectCompletedPhase 4University of MilanNCT01437748Written as Indacaterol maleate
- Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related DyspneaCompletedPhase 4University of MilanNCT01377051Written as Indacaterol maleate
- Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With AsthmaCompletedPhase 2Novartis PharmaceuticalsNCT00927901Written as Indacaterol maleate 400 μg
- Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With AsthmaCompletedPhase 2NovartisNCT00556673Written as indacaterol maleate/mometasone furoate
- Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate AsthmaCompletedPhase 2NovartisNCT00605306Written as indacaterol maleate / mometasone furoate
- Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent AsthmaCompletedPhase 2NovartisNCT00557440Written as indacaterol maleate / mometasone furoate
- Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2/3NovartisNCT00396604Written as indacaterol maleate
Given in every arm · 1 — indacaterol maleate is usual care beside what is tested
As the comparator · 1 — what is tested is compared with indacaterol maleate
Codes
What other systems call indacaterol maleate · ClinicalTrials.gg INT014488
- UNII (FDA) 2JEC1ITX7RINDACATEROL MALEATEConfirmed FDA, Wikidata
- RxNorm 1114325Confirmed FDA, Wikidata
- Wikidata Q27137018indacaterol maleateConfirmed FDA, Wikidata
- NCI Thesaurus C81640Indacaterol MaleateOne source FDA
- DrugBank DBSALT000101One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2JEC1ITX7R | INDACATEROL MALEATE | Confirmed FDA, Wikidata |
| RxNorm | 1114325 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27137018 | indacaterol maleate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C81640 | Indacaterol Maleate | One source FDA |
| DrugBank | DBSALT000101 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.